Blaine Davis Biography and Net Worth

Blaine Davis serves as Chief Financial Officer of Cartesian Therapeutics. He brings more than 25 years of executive leadership experience in investor relations, corporate affairs, and sales and marketing at life sciences companies. Prior to Cartesian’s merger with Selecta in November 2023, he served as Chief Financial Officer of Selecta. Before joining Selecta, Blaine was the Chief Financial Officer of Protara Therapeutic. Prior to joining Protara, Blaine served as Vice President, Head of Investor Relations and Corporate Communications at Insmed starting in July 2017. Previously, he held multiple executive leadership positions at Endo International, including Senior Vice President and General Manager, Specialty Pharmaceuticals; President of Endo Ventures; and Senior Vice President, Investor Relations and Corporate Communications. Prior to Endo, Blaine held senior positions in corporate and business development and investor relations at Bristol-Myers Squibb.

Blaine holds a BA in Biology and Psychology with a minor in Economics from Middlebury College.

What is Blaine Davis' net worth?: The estimated net worth of Blaine Davis is at least $654.20 thousand as of January 6th, 2025. Mr. Davis owns 94,811 shares of Cartesian Therapeutics stock worth more than $654,196 as of December 5th. This net worth estimate does not reflect any other investments that Mr. Davis may own. Additionally, Mr. Davis receives an annual salary of $2,490,000.00 as CFO at Cartesian Therapeutics. Learn More about Blaine Davis' net worth.
How old is Blaine Davis?: Mr. Davis is currently 50 years old. There are 5 older executives and no younger executives at Cartesian Therapeutics. The oldest executive at Cartesian Therapeutics is Dr. Carsten Brunn Ph.D., President, CEO & Director, who is 53 years old. Learn More on Blaine Davis' age.
What is Blaine Davis' salary?: As the CFO of Cartesian Therapeutics, Inc., Mr. Davis earns $2,490,000.00 per year. The highest earning executive at Cartesian Therapeutics is Dr. Carsten Brunn Ph.D., President, CEO & Director, who commands a salary of $4,670,000.00 per year. Learn More on Blaine Davis' salary.
How do I contact Blaine Davis?: The corporate mailing address for Mr. Davis and other Cartesian Therapeutics executives is 65 Grove Street, Watertown, MA 02472, United States. Cartesian Therapeutics can also be reached via phone at 617-923-1400 and via email at [email protected]. Learn More on Blaine Davis' contact information.
Has Blaine Davis been buying or selling shares of Cartesian Therapeutics?: Blaine Davis has not been actively trading shares of Cartesian Therapeutics over the course of the past ninety days. Most recently, Blaine Davis sold 4,028 shares of the business's stock in a transaction on Monday, January 6th. The shares were sold at an average price of $16.83, for a transaction totalling $67,791.24. Following the completion of the sale, the chief financial officer now directly owns 94,811 shares of the company's stock, valued at $1,595,669.13. Learn More on Blaine Davis' trading history.
Who are Cartesian Therapeutics' active insiders?: Cartesian Therapeutics' insider roster includes Blaine Davis (CFO), Miloš Miljković (Chief Medical Officer), and Timothy Springer (Director). Learn More on Cartesian Therapeutics' active insiders.
Are insiders buying or selling shares of Cartesian Therapeutics?: During the last year, insiders at the sold shares 6 times. They sold a total of 14,744 shares worth more than $247,337.42. The most recent insider tranaction occured on January, 6th when CTO Metin Kurtoglu sold 2,458 shares worth more than $41,368.14. Insiders at Cartesian Therapeutics own 60.3% of the company. Learn More about insider trades at Cartesian Therapeutics.
Information on this page was last updated on 1/6/2025.

Blaine Davis Insider Trading History at Cartesian Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
1/6/2025	Sell	4,028	$16.83	$67,791.24	94,811
1/3/2025	Sell	3,961	$16.72	$66,227.92	98,839

Blaine Davis Buying and Selling Activity at Cartesian Therapeutics

Cartesian Therapeutics Company Overview

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, engages in the provision of mRNA cell therapies for the treatment of autoimmune diseases. It develops Descartes-08, an autologous anti-BCMA RNA-engineered chimeric antigen receptor T-cell therapy, currently under Phase 2b clinical development for generalized myasthenia gravis, as well as for patients with systemic lupus erythematosus, and myeloma autoimmune basket trials for other autoimmune diseases. The company develops Descartes-15 to treat Autoimmune diseases, myeloma; and Descartes-33 which is in preclinical development for treatment of autoimmune diseases. Cartesian Therapeutics, Inc. is headquartered in Gaithersburg, Maryland.

Today's Range

Now: $6.90

$6.53

$7.00

50 Day Range

MA: $8.43

$6.65

$10.34

2 Week Range

Now: $6.90

$5.98

$26.50

Volume

364,771 shs

Average Volume

129,291 shs

Market Capitalization

$179.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.36

Blaine Davis Biography and Net Worth

What is Blaine Davis' net worth?

How old is Blaine Davis?

What is Blaine Davis' salary?

How do I contact Blaine Davis?

Has Blaine Davis been buying or selling shares of Cartesian Therapeutics?

Who are Cartesian Therapeutics' active insiders?

Are insiders buying or selling shares of Cartesian Therapeutics?